HWAM
TGTX icon

Hennion & Walsh Asset Management’s TG Therapeutics TGTX Stock Holding History

Hennion & Walsh Asset Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-79,032
Closed -$2.86M – 993
2025
Q3 		$2.86M Sell
79,032
-14,739
-16% -$485K 0.1% 255
2025
Q2 		$3.37M Sell
93,771
-1,400
-1% -$52.1K 0.14% 191
2025
Q1 		$3.75M Sell
95,171
-2,462
-3% -$82.8K 0.17% 155
2024
Q4 		$2.94M Sell
97,633
-996
-1% -$28.6K 0.13% 194
2024
Q3 		$2.31M Sell
98,629
-2,740
-3% -$59.8K 0.11% 244
2024
Q2 		$1.8M Sell
101,369
-83,446
-45% -$1.33M 0.09% 273
2024
Q1 		$2.81M Buy
184,815
+26,761
+17% +$426K 0.15% 187
2023
Q4 		$2.7M Buy
158,054
+31,868
+25% +$370K 0.15% 192
2023
Q3 		$1.05M Sell
126,186
-3,570
-3% -$49.8K 0.07% 347
2023
Q2 		$3.22M Sell
129,756
-1,872
-1% -$48.4K 0.19% 133
2023
Q1 		$1.98M Sell
131,628
-3,814
-3% -$57.9K 0.12% 209
2022
Q4 		$1.6M Sell
135,442
-68,140
-33% -$495K 0.1% 242
2022
Q3 		$1.21M Buy
203,582
+13,913
+7% +$91.3K 0.08% 287
2022
Q2 		$806K Buy
189,669
+60,149
+46% +$376K 0.05% 369
2022
Q1 		$1.23M Buy
129,520
+11,585
+10% +$134K 0.07% 296
2021
Q4 		$2.24M Buy
117,935
+14,121
+14% +$367K 0.11% 217
2021
Q3 		$3.46M Sell
103,814
-2,289
-2% -$70.8K 0.18% 164
2021
Q2 		$4.12M Buy
106,103
+14,648
+16% +$575K 0.22% 117
2021
Q1 		$4.41M Buy
+91,455
New +$4.39M 0.26% 97

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Hennion & Walsh Asset Management's TGTX Position: Q4 2025 in Review

Hennion & Walsh Asset Management sold out of TG Therapeutics (TGTX) in Q4 2025, closing a stake of 79,032 shares — an estimated $2.86M sold.

Hennion & Walsh Asset Management first reported a position in TGTX in Q1 2021 and held it in 19 quarters. The position peaked at $4.41M in Q1 2021. 351 funds tracked by Wall St. Rank hold TGTX as of Q4 2025.

  • Hennion & Walsh Asset Management reported no remaining TG Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 79,032 TG Therapeutics shares in Q4 2025, an estimated $2.86M.
  • Hennion & Walsh Asset Management first reported a position in TG Therapeutics in Q1 2021 and held it in 19 quarters.
  • Hennion & Walsh Asset Management's TG Therapeutics position peaked at $4.41M in Q1 2021.
  • 351 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2025.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2025, filed 14 Jan 2026.